169 related articles for article (PubMed ID: 36871221)
1. Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma.
Rajendran S; Hu Y; Canella A; Peterson C; Gross A; Cam M; Nazzaro M; Haffey A; Serin-Harmanci A; Distefano R; Nigita G; Wang W; Kreatsoulas D; Li Z; Sepeda JA; Sas A; Hester ME; Miller KE; Elemento O; Roberts RD; Holland EC; Rao G; Mardis ER; Rajappa P
Cell Rep; 2023 Mar; 42(3):112197. PubMed ID: 36871221
[TBL] [Abstract][Full Text] [Related]
2. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
[TBL] [Abstract][Full Text] [Related]
3. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
Front Immunol; 2021; 12():668391. PubMed ID: 34539622
[TBL] [Abstract][Full Text] [Related]
4. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
5. Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens.
Weenink B; Draaisma K; Ooi HZ; Kros JM; Sillevis Smitt PAE; Debets R; French PJ
Sci Rep; 2019 Oct; 9(1):14643. PubMed ID: 31601888
[TBL] [Abstract][Full Text] [Related]
6. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
Scholl JN; Weber AF; Dias CK; Lima VP; Grun LK; Zambonin D; Anzolin E; Dos Santos Dias WW; Kus WP; Barbé-Tuana F; Battastini AMO; Worm PV; Figueiró F
Purinergic Signal; 2024 Feb; 20(1):47-64. PubMed ID: 36964277
[TBL] [Abstract][Full Text] [Related]
7. Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment.
Canella A; Nazzaro M; Rajendran S; Schmitt C; Haffey A; Nigita G; Thomas D; Lyberger JM; Behbehani GK; Amankulor NM; Mardis ER; Cripe TP; Rajappa P
Cell Rep; 2023 Aug; 42(8):112891. PubMed ID: 37516967
[TBL] [Abstract][Full Text] [Related]
8. Specialized functions and sexual dimorphism explain the functional diversity of the myeloid populations during glioma progression.
Ochocka N; Segit P; Wojnicki K; Cyranowski S; Swatler J; Jacek K; Grajkowska W; Kaminska B
Cell Rep; 2023 Jan; 42(1):111971. PubMed ID: 36640350
[TBL] [Abstract][Full Text] [Related]
9. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
11. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Gressot LV; Doucette T; Yang Y; Fuller GN; Manyam G; Rao A; Latha K; Rao G
Oncotarget; 2017 Feb; 8(8):12695-12704. PubMed ID: 27074575
[TBL] [Abstract][Full Text] [Related]
13. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract][Full Text] [Related]
14. Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.
Alghamri MS; Kamran N; Kadiyala P; Lowenstein PR; Castro MG
Methods Enzymol; 2020; 632():215-228. PubMed ID: 32000897
[TBL] [Abstract][Full Text] [Related]
15. [Whole-genome messenger RNA profiling reveals genes involved in malignant progression of glioma].
Yang P; Yan W; Zhang W; You G; Bao ZS; Jiang T
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):5-7. PubMed ID: 23578443
[TBL] [Abstract][Full Text] [Related]
16. CD8
Kane JR; Zhao J; Tsujiuchi T; Laffleur B; Arrieta VA; Mahajan A; Rao G; Mela A; Dmello C; Chen L; Zhang DY; González-Buendia E; Lee-Chang C; Xiao T; Rothschild G; Basu U; Horbinski C; Lesniak MS; Heimberger AB; Rabadan R; Canoll P; Sonabend AM
Clin Cancer Res; 2020 Aug; 26(16):4390-4401. PubMed ID: 32430477
[TBL] [Abstract][Full Text] [Related]
17. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
18. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.
Venteicher AS; Tirosh I; Hebert C; Yizhak K; Neftel C; Filbin MG; Hovestadt V; Escalante LE; Shaw ML; Rodman C; Gillespie SM; Dionne D; Luo CC; Ravichandran H; Mylvaganam R; Mount C; Onozato ML; Nahed BV; Wakimoto H; Curry WT; Iafrate AJ; Rivera MN; Frosch MP; Golub TR; Brastianos PK; Getz G; Patel AP; Monje M; Cahill DP; Rozenblatt-Rosen O; Louis DN; Bernstein BE; Regev A; Suvà ML
Science; 2017 Mar; 355(6332):. PubMed ID: 28360267
[TBL] [Abstract][Full Text] [Related]
19. [The immunosuppressive microenvironment of malignant gliomas].
Borisov KE; Sakaeva DD
Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
[TBL] [Abstract][Full Text] [Related]
20. A distinct microglial subset at the tumor-stroma interface of glioma.
Caponegro MD; Oh K; Madeira MM; Radin D; Sterge N; Tayyab M; Moffitt RA; Tsirka SE
Glia; 2021 Jul; 69(7):1767-1781. PubMed ID: 33704822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
